Drug Manufacturers - Specialty & Generic

Regencell Bioscience Holdings (RGC) – Bearish Momentum Persists Despite Oversold RSI

Regencell Bioscience Holdings (RGC) is facing a confluence of negative fundamentals, deteriorating financials, and overwhelmingly bearish news sentiment. The stock has plunged 80% over the past year and recently dropped 11.42% in a single day. While the RSI of 17.08 signals extreme oversold conditions, the absence of any positive catalyst and continued operational losses suggest further downside is likely in the short term. The prediction is a decrease over the next 5 days, with moderate confidence due to the oversold technical reading.